|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reck M, Popat S, Reinmuth N, De Ruysscher
D, Kerr KM and Peters S: ESMO Guidelines Working Group: Metastatic
non-small-cell lung cancer (NSCLC): ESMO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol. 25
Suppl 3:iii27–iii39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Field JK, Oudkerk M, Pedersen JH and Duffy
SW: Prospects for population screening and diagnosis of lung
cancer. Lancet. 382:732–741. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Minna JD, Roth JA and Gazdar AF: Focus on
lung cancer. Cancer Cell. 1:49–52. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han L, Witmer PD, Casey E, Valle D and
Sukumar S: DNA methylation regulates MicroRNA expression. Cancer
Biol Ther. 6:1284–1288. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kozaki K, Imoto I, Mogi S, Omura K and
Inazawa J: Exploration of tumor-suppressive microRNAs silenced by
DNA hypermethylation in oral cancer. Cancer Res. 68:2094–2105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, et al: miR-124 and miR-137 inhibit proliferation of
glioblastoma multiforme cells and induce differentiation of brain
tumor stem cells. BMC Med. 6(14)2008.PubMed/NCBI
|
|
12
|
Zhang B, Liu T, Wu T, Wang Z, Rao Z and
Gao J: microRNA-137 functions as a tumor suppressor in human
non-small cell lung cancer by targeting SLC22A18. Int J Biol
Macromol. 74:111–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bier A, Giladi N, Kronfeld N, Lee HK,
Cazacu S, Finniss S, Xiang C, Poisson L, deCarvalho AC, Slavin S,
et al: MicroRNA-137 is downregulated in glioblastoma and inhibits
the stemness of glioma stem cells by targeting RTVP-1. Oncotarget.
4:665–676. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen L, Wang X, Wang H, Li Y, Yan W, Han
L, Zhang K, Zhang J, Wang Y, Feng Y, et al: miR-137 is frequently
down-regulated in glioblastoma and is a negative regulator of
Cox-2. Eur J Cancer. 48:3104–3111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Q, Chen X, Zhang M, Fan Q, Luo S and
Cao X: miR-137 is frequently down-regulated in gastric cancer and
is a negative regulator of Cdc42. Dig Dis Sci. 56:2009–2016. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Balaguer F, Link A, Lozano JJ, Cuatrecasas
M, Nagasaka T, Boland CR and Goel A: Epigenetic silencing of
miR-137 is an early event in colorectal carcinogenesis. Cancer Res.
70:6609–6618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Steponaitiene R, Kupcinskas J, Langner C,
Balaguer F, Venclauskas L, Pauzas H, Tamelis A, Skieceviciene J,
Kupcinskas L, Malfertheiner P and Link A: Epigenetic silencing of
miR-137 is a frequent event in gastric carcinogenesis. Mol
Carcinog. 55:376–386. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Langevin SM, Stone RA, Bunker CH,
Lyons-Weiler MA, LaFramboise WA, Kelly L, Seethala RR, Grandis JR,
Sobol RW and Taioli E: MicroRNA-137 promoter methylation is
associated with poorer overall survival in patients with squamous
cell carcinoma of the head and neck. Cancer. 117:1454–1462. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kang N, Choi SY, Kim YK, Yoo IeR, Han DH,
Lee DS, Kim YS, Hong SH, Kang JH, Lee KY, et al: Silencing of
miR-137 by aberrant promoter hypermethylation in surgically
resected lung cancer. Lung Cancer. 89:99–103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reddel RR, Ke Y, Gerwin BI, McMenamin MG,
Lechner JF, Su RT, Brash DE, Park JB, Rhim JS and Harris CC:
Transformation of human bronchial epithelial cells by infection
with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via
strontium phosphate coprecipitation with a plasmid containing SV40
early region genes. Cancer Res. 48:1904–1909. 1988.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shepherd FA, Crowley J, Van Houtte P,
Postmus PE, Carney D, Chansky K, Shaikh Z and Goldstraw P;
International Association for the Study of Lung Cancer
International Staging Committee and Participating Institutions, .
The international association for the study of lung cancer lung
cancer staging project: Proposals regarding the clinical staging of
small cell lung cancer in the forthcoming (seventh) edition of the
tumor, node, metastasis classification for lung cancer. J Thorac
Oncol. 2:1067–1077. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dacic S, Kelly L, Shuai Y and Nikiforova
MN: miRNA expression profiling of lung adenocarcinomas: Correlation
with mutational status. Mod Pathol. 23:1577–1582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bemis LT, Chen R, Amato CM, Classen EH,
Robinson SE, Coffey DG, Erickson PF, Shellman YG and Robinson WA:
MicroRNA-137 targets microphthalmia-associated transcription factor
in melanoma cell lines. Cancer Res. 68:1362–1368. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deng Y, Deng H, Bi F, Liu J, Bemis LT,
Norris D, Wang XJ and Zhang Q: MicroRNA-137 targets
carboxyl-terminal binding protein 1 in melanoma cell lines. Int J
Biol Sci. 7:133–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y
and He F: miR-137 targets estrogen-related receptor alpha and
impairs the proliferative and migratory capacity of breast cancer
cells. PLoS One. 7:e391022012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu X, Li Y, Shen H, Li H, Long L, Hui L
and Xu W: miR-137 inhibits the proliferation of lung cancer cells
by targeting Cdc42 and Cdk6. FEBS Lett. 587:73–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bi Y, Han Y, Bi H, Gao F and Wang X:
miR-137 impairs the proliferative and migratory capacity of human
non-small cell lung cancer cells by targeting paxillin. Hum Cell.
27:95–102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li P, Ma L, Zhang Y, Ji F and Jin F:
MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer
cell proliferation. Biomed Pharmacother. 68:7–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
